Morning Movers 02/15: (BPAX) (EGY) (IPAS) (CBK) Higher; (VG) (ZNGA) (ACPW) Lower
Down)
BioSante Pharma (Nasdaq: BPAX) 37.9% HIGHER; the company and Teva Pharma (Nasdaq: TEVA) have received FDA approval for Bio-T-Gel for men with low testosterone.
VAALCO Energy, Inc. (NYSE: EGY) 19.1% HIGHER; provided an update on the company's working interest in Block 5 offshore Angola. VAALCO recently received written confirmation from the Angolan national oil company, Sonangol, that the government of Angola has granted a time extension of the production sharing agreement for Block 5 through the end of 2012.
iPass Inc. (NASDAQ: IPAS) 16.7% HIGHER; today announced that China Telecom Corporation Limited has joined the iPass Open Mobile Exchange (iPass OMX), the largest global Wi-Fi exchange community, to provide international Wi-Fi roaming services through iPass for China Telecom subscribers.
Vonage Holdings (NYSE: VG) 15.4% LOWER; reported Q4 EPS of $0.11, in-line with the analyst estimate of $0.11. Revenue for the quarter came in at $215.69 million versus the consensus estimate of $218.01 million.
Christopher & Banks (NYSE: CBK) 14.6% HIGHER; likely moving on technicals this morning. The stock jumped over the 200-day SMA and is also above resistance at $2.50.
Zynga (NASDAQ: ZNGA) 14.3% LOWER; reported Q4 EPS of $0.05, $0.02 better than the analyst estimate of $0.03. Revenue for the quarter came in at $311.2 million. Zynga sees FY2012 EPS of $0.24-$0.28. The stock was downgraded at Baird, Barclays and Evercore.
Dean Foods Co. (NYSE: DF) 13.6% HIGHER; reported Q4 EPS of $0.27, $0.04 better than the analyst estimate of $0.23. Revenue for the quarter came in at $3.3 billion versus the consensus estimate of $3.34 billion. Sees Q1 2012 EPS of $0.18-$0.23, versus the consensus of $0.19. Sees FY2012 EPS of $0.87-$0.95, versus the consensus of $0.89.
Active Power, Inc. (NASDAQ: ACPW) 13.2% LOWER; reported Q4 EPS of ($0.04), $0.03 worse than the analyst estimate of ($0.01). Revenue for the quarter came in at $18.3 million versus the consensus estimate of $19.93 million. Sees Q1 2012 EPS of $-0.01-$-0.03, versus the consensus of $-0.01. Sees Q1 2012 revenue of $17-$21 million, versus the consensus of $19.6 million.
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) 12.5% HIGHER; announced favorable preclinical results for BCX5191, a novel adenine nucleoside analog targeting viral RNA polymerase for the potential treatment of hepatitis C. BioCryst has successfully completed in vitro and in vivo studies in which BCX5191 exhibited potent and selective pan-genotypic antiviral activity against the hepatitis C polymerase enzyme. BCX5191 showed no inhibition of human RNA polymerase and no evidence of toxicity from standard in vitro screens.
Abercrombie & Fitch Co. (NYSE: ANF) 12% HIGHER; reported Q4 EPS of $1.12, in-line with the analyst estimate of $1.12. Revenue for the quarter came in at $1.33 billion versus the consensus estimate of $1.33 billion.
WellCare Health Plans, Inc. (NYSE: WCG) 11.6% HIGHER; reported Q4 EPS of $2.15, $0.97 better than the analyst estimate of $1.18. Revenue for the quarter came in at $1.58 billion versus the consensus estimate of $1.59 billion. Sees FY2012 EPS of $4.40-$4.60, versus the consensus of $4.21.
Lee Enterprises (NYSE: LEE) 10.9% HIGHER; bouncing above the 200-day SMA this morning.
Powerwave Technologies, Inc. (NASDAQ: PWAV) 10.8% LOWER; reported Q4 EPS of ($1.34), which may not compare to the analyst estimate of ($0.61). Revenue for the quarter came in at $60.1 million versus the consensus estimate of $90.94 million.
Atlas Air Worldwide Holdings, Inc. (NASDAQ: AAWW) 10.5% LOWER; reported Q4 EPS of $1.50, $0.39 worse than the analyst estimate of $1.89. Revenue for the quarter came in at $388.2 million versus the consensus estimate of $410.78 million. Sees FY2012 EPS exceeding $5.10, versus the consensus of $5.62.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
VAALCO Energy, Inc. (NYSE: EGY) 19.1% HIGHER; provided an update on the company's working interest in Block 5 offshore Angola. VAALCO recently received written confirmation from the Angolan national oil company, Sonangol, that the government of Angola has granted a time extension of the production sharing agreement for Block 5 through the end of 2012.
iPass Inc. (NASDAQ: IPAS) 16.7% HIGHER; today announced that China Telecom Corporation Limited has joined the iPass Open Mobile Exchange (iPass OMX), the largest global Wi-Fi exchange community, to provide international Wi-Fi roaming services through iPass for China Telecom subscribers.
Vonage Holdings (NYSE: VG) 15.4% LOWER; reported Q4 EPS of $0.11, in-line with the analyst estimate of $0.11. Revenue for the quarter came in at $215.69 million versus the consensus estimate of $218.01 million.
Christopher & Banks (NYSE: CBK) 14.6% HIGHER; likely moving on technicals this morning. The stock jumped over the 200-day SMA and is also above resistance at $2.50.
Zynga (NASDAQ: ZNGA) 14.3% LOWER; reported Q4 EPS of $0.05, $0.02 better than the analyst estimate of $0.03. Revenue for the quarter came in at $311.2 million. Zynga sees FY2012 EPS of $0.24-$0.28. The stock was downgraded at Baird, Barclays and Evercore.
Dean Foods Co. (NYSE: DF) 13.6% HIGHER; reported Q4 EPS of $0.27, $0.04 better than the analyst estimate of $0.23. Revenue for the quarter came in at $3.3 billion versus the consensus estimate of $3.34 billion. Sees Q1 2012 EPS of $0.18-$0.23, versus the consensus of $0.19. Sees FY2012 EPS of $0.87-$0.95, versus the consensus of $0.89.
Active Power, Inc. (NASDAQ: ACPW) 13.2% LOWER; reported Q4 EPS of ($0.04), $0.03 worse than the analyst estimate of ($0.01). Revenue for the quarter came in at $18.3 million versus the consensus estimate of $19.93 million. Sees Q1 2012 EPS of $-0.01-$-0.03, versus the consensus of $-0.01. Sees Q1 2012 revenue of $17-$21 million, versus the consensus of $19.6 million.
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) 12.5% HIGHER; announced favorable preclinical results for BCX5191, a novel adenine nucleoside analog targeting viral RNA polymerase for the potential treatment of hepatitis C. BioCryst has successfully completed in vitro and in vivo studies in which BCX5191 exhibited potent and selective pan-genotypic antiviral activity against the hepatitis C polymerase enzyme. BCX5191 showed no inhibition of human RNA polymerase and no evidence of toxicity from standard in vitro screens.
Abercrombie & Fitch Co. (NYSE: ANF) 12% HIGHER; reported Q4 EPS of $1.12, in-line with the analyst estimate of $1.12. Revenue for the quarter came in at $1.33 billion versus the consensus estimate of $1.33 billion.
WellCare Health Plans, Inc. (NYSE: WCG) 11.6% HIGHER; reported Q4 EPS of $2.15, $0.97 better than the analyst estimate of $1.18. Revenue for the quarter came in at $1.58 billion versus the consensus estimate of $1.59 billion. Sees FY2012 EPS of $4.40-$4.60, versus the consensus of $4.21.
Lee Enterprises (NYSE: LEE) 10.9% HIGHER; bouncing above the 200-day SMA this morning.
Powerwave Technologies, Inc. (NASDAQ: PWAV) 10.8% LOWER; reported Q4 EPS of ($1.34), which may not compare to the analyst estimate of ($0.61). Revenue for the quarter came in at $60.1 million versus the consensus estimate of $90.94 million.
Atlas Air Worldwide Holdings, Inc. (NASDAQ: AAWW) 10.5% LOWER; reported Q4 EPS of $1.50, $0.39 worse than the analyst estimate of $1.89. Revenue for the quarter came in at $388.2 million versus the consensus estimate of $410.78 million. Sees FY2012 EPS exceeding $5.10, versus the consensus of $5.62.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- Streetinsider.com's Hot Lunchtime Reads 05/25: (HAS) (ADP) (EMC) (PAY)
- Trading Radar for 05/24: Costco (COST), H.J. Heinz (HNZ), Tiffany & Co. (TIF), VeriFone (PAY) Report
- Unusual 11 Mid-Day Movers 05/25: (GNOM) (UPI) (RPRX) Higher; (TLB) (DCTH) (PAY) Lower
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Robert W Baird, Barclays, Morning MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
